Results 21 to 30 of about 14,528 (265)

Managing Alpha-Gal Allergy in a Case of Bioprosthetic TAVR. [PDF]

Case Reports Immunol
Alpha‐gal syndrome (AGS) is an uncommon IgE‐mediated allergy to mammalian‐derived products, caused by sensitization to the oligosaccharide galactose‐α‐1,3‐galactose (alpha‐gal) after tick exposure. Although AGS is best recognized for delayed anaphylaxis following ingestion of red meat, its implications for exposure to mammalian‐derived biomaterials ...
Patel R, Patel A, Biswas R, Hsieh B, Ramasamy D, Patel C.   +5 more
europepmc   +2 more sources

Sutureless aortic bioprosthesis [PDF]

Interactive CardioVascular and Thoracic Surgery, 2017
Aortic valve replacement (AVR) is the treatment of choice for aortic valve disease, with excellent results reported in the short- and long-term follow-up. Due to the increasing number of patient comorbidities and older age, various technical alternatives have been developed such as transcatheter aortic valve implantation and, more recently, sutureless ...
José, Martínez-Comendador, Mario, Castaño, Javier, Gualis, Elio, Martín, Pasquale, Maiorano, Javier, Otero   +5 more
openaire   +2 more sources

Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis.

EuroIntervention, 2021
BACKGROUND Limited data are available regarding clinical outcomes of valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) following the United States Food and Drug Administration approval of ViV TAVI in 2015.
M. Majmundar, R. Doshi, Ashish Kumar, Douglas Johnston, James Brockett, Anmar Kanaa’n, J. Lahorra, L. Svensson, A. Krishnaswamy, G. Reed, R. Puri, S. Kapadia, A. Kalra   +12 more
semanticscholar   +1 more source

Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50–70 Years

Frontiers in Cardiovascular Medicine, 2022
BackgroundRheumatic heart disease (RHD) is a critical problem in developing countries and is the cause of most of the cardiovascular adverse events in young people.
Jun Yu, Wei Wang
doaj   +1 more source

Early Structural Valve Degeneration of Trifecta Bioprosthesis.

Annals of Thoracic Surgery, 2020
BACKGROUND Structural valve deterioration (SVD) is a major flaw of bioprostheses. We recently observed an apparent increase in the SVD rate among those received the Trifecta bioprosthesis.
S. Fukuhara, Suzuna Shiomi, Bo Yang, Karen M Kim, S. Bolling, J. Haft, P. Tang, F. Pagani, R. Prager, S. Chetcuti, P. Grossman, H. Patel, G. Deeb   +12 more
semanticscholar   +1 more source

Platelet Reduction after Aortic Bioprosthesis Implantation:Results from the PORTRAIT Study [PDF]

, 2023
: Platelet count reduction (PR) is a common but unclear phenomenon that occurs after aortic bioprosthesis valve implantation (bio-AVR). This study aimed to investigate the occurrence and clinical impact of PR in patients receiving stented, rapid ...
Jiritano, Federica, Giuseppe Filiberto Serraino, Domenico Paparella, Federica Jiritano, Dario Fina, Giangiuseppe Cappabianca, Lorusso, Roberto, Pasquale Mastroroberto, Di Mauro, Michele, Theodor Fischlein, Caporali, Elena, Falcetta, Giosuè, Patanè, Leonardo, Visicchio, Giuseppe, Mastroroberto, Pasquale, Michele Di Mauro, Elena Caporali, Roberto Scrofani, Giuseppe Visicchio, Matteo Matteucci, Borelli, Massimo, Mariusz Kowalewski, Fina, Dario, Paparella, Domenico, Andrea Colli, Fischlein, Theodor, Massimo Borelli, Pollari, Francesco, Cappabianca, Giangiuseppe, Francesco Pollari, Roberto Lorusso, Colli, Andrea, Matteucci, Matteo, Kowalewski, Mariusz, Giosuè Falcetta, Scrofani, Roberto, Serraino, Giuseppe Filiberto, Leonardo Patanè   +37 more
core   +1 more source

Surgical explantation of transcatheter aortic bioprosthesis: A systematic review and meta-analysis

JTCVS Open, 2021
Background Despite the rapid adoption of transcatheter aortic valve replacement (TAVR), aortic valve reintervention, particularly surgical TAVR valve explantation (TAVR explant), has not been well described.
Y. Yokoyama, T. Kuno, S. Zaid, T. Kaneko, H. Takagi, G. Tang, S. Fukuhara   +6 more
semanticscholar   +1 more source

Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis

European Journal of Cardio-Thoracic Surgery, 2020
OBJECTIVES Long-term durability of bioprosthetic valves is predominantly limited by structural valve deterioration. RESILIA™ tissue has exhibited reduced calcification in pre-clinical and early clinical studies.
K. Bartus, R. Litwinowicz, A. Bilewska, M. Stąpór, M. Bochenek, J. Różański, J. Sadowski, Grzegorz Filip, M. Kuśmierczyk, B. Kapelak   +9 more
semanticscholar   +1 more source

Degeneration of Bioprosthetic Heart Valves: Update 2020

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
The implantation of bioprosthetic heart valves (BHVs) is increasingly becoming the treatment of choice in patients requiring heart valve replacement surgery.
Alexander E. Kostyunin, Arseniy E. Yuzhalin, Maria A. Rezvova, Evgeniy A. Ovcharenko, Tatiana V. Glushkova, Anton G. Kutikhin   +5 more
doaj   +1 more source

Valve-shaped thrombus underneath an aortic bioprosthesis [PDF]

, 2021
We describe massive thrombus formation completely occluding an aortic bioprosthesis in a patient with venoarterial extracorporeal membrane oxygenation and apical venting. The thrombus was surgically removed and the patient recovered with no complications.
Cibin G., Fabozzo A., D'Onofrio A., Tarzia V., Gerosa G.   +4 more
core   +1 more source